ATE511506T1 - Thiopen-derivate als wirkstoffe gegen okulare hypotonie - Google Patents
Thiopen-derivate als wirkstoffe gegen okulare hypotonieInfo
- Publication number
- ATE511506T1 ATE511506T1 AT08713891T AT08713891T ATE511506T1 AT E511506 T1 ATE511506 T1 AT E511506T1 AT 08713891 T AT08713891 T AT 08713891T AT 08713891 T AT08713891 T AT 08713891T AT E511506 T1 ATE511506 T1 AT E511506T1
- Authority
- AT
- Austria
- Prior art keywords
- thiopene
- occular
- hypotonia
- derivatives
- active ingredients
- Prior art date
Links
- 206010021118 Hypotonia Diseases 0.000 title 1
- 208000007379 Muscle Hypotonia Diseases 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010030043 Ocular hypertension Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88601307P | 2007-01-22 | 2007-01-22 | |
PCT/US2008/051650 WO2008091860A1 (en) | 2007-01-22 | 2008-01-22 | Thiophene derivatives useful as ocular hypotensive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE511506T1 true ATE511506T1 (de) | 2011-06-15 |
Family
ID=39420781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08713891T ATE511506T1 (de) | 2007-01-22 | 2008-01-22 | Thiopen-derivate als wirkstoffe gegen okulare hypotonie |
Country Status (7)
Country | Link |
---|---|
US (1) | US8039496B2 (de) |
EP (1) | EP2114913B1 (de) |
JP (1) | JP5394933B2 (de) |
AT (1) | ATE511506T1 (de) |
AU (1) | AU2008207991B9 (de) |
CA (1) | CA2675981A1 (de) |
WO (1) | WO2008091860A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2447065T3 (es) * | 2006-07-10 | 2014-03-11 | Allergan, Inc. | Derivados de ciclopentano sustituidos como agentes terapeuticos |
ES2735217T3 (es) * | 2008-04-24 | 2019-12-17 | Allergan Inc | Arilciclopentenos sustituidos como agentes terapéuticos |
US7803798B2 (en) * | 2008-04-24 | 2010-09-28 | Allergan, Inc. | Therapeutic compounds |
WO2015129782A1 (ja) * | 2014-02-27 | 2015-09-03 | 小野薬品工業株式会社 | 選択的ep2アゴニスト活性を有する化合物 |
US10385045B2 (en) | 2015-07-23 | 2019-08-20 | Ono Pharmaceutical Co., Ltd. | Compound having EP2 agonist activity |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US6291522B1 (en) * | 2000-09-27 | 2001-09-18 | Allergan Sales, Inc. | Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
BR0213911A (pt) * | 2001-11-05 | 2004-09-28 | Allergan Inc | Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2 |
US7183310B2 (en) * | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
US7429669B2 (en) * | 2006-06-20 | 2008-09-30 | Allergan, Inc. | Therapeutic compounds |
US7507817B2 (en) * | 2006-11-17 | 2009-03-24 | Allergan, Inc. | Prostaglandin prodrugs |
ES2735217T3 (es) * | 2008-04-24 | 2019-12-17 | Allergan Inc | Arilciclopentenos sustituidos como agentes terapéuticos |
US7803798B2 (en) * | 2008-04-24 | 2010-09-28 | Allergan, Inc. | Therapeutic compounds |
-
2008
- 2008-01-22 WO PCT/US2008/051650 patent/WO2008091860A1/en active Application Filing
- 2008-01-22 CA CA002675981A patent/CA2675981A1/en not_active Abandoned
- 2008-01-22 JP JP2009547377A patent/JP5394933B2/ja not_active Expired - Fee Related
- 2008-01-22 EP EP08713891A patent/EP2114913B1/de not_active Not-in-force
- 2008-01-22 AU AU2008207991A patent/AU2008207991B9/en not_active Ceased
- 2008-01-22 US US12/523,409 patent/US8039496B2/en active Active
- 2008-01-22 AT AT08713891T patent/ATE511506T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP5394933B2 (ja) | 2014-01-22 |
US20100029735A1 (en) | 2010-02-04 |
US8039496B2 (en) | 2011-10-18 |
AU2008207991B2 (en) | 2014-01-16 |
JP2010516779A (ja) | 2010-05-20 |
AU2008207991A1 (en) | 2008-07-31 |
EP2114913A1 (de) | 2009-11-11 |
CA2675981A1 (en) | 2008-07-31 |
AU2008207991B9 (en) | 2014-02-27 |
WO2008091860A1 (en) | 2008-07-31 |
EP2114913B1 (de) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
ATE517882T1 (de) | Chinolinderivate | |
NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
DE602004028150D1 (de) | Aminopyrazolderivate als gsk-3-inhibitoren | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
ATE540932T1 (de) | Hydantoin-derivate als antibakterielle wirkstoffe | |
NO20084872L (no) | 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig | |
DE602007013391D1 (de) | Cyclosporins zur behandlung und vorbeugung von augenerkrankungen | |
SE0401971D0 (sv) | Piperidne derivatives | |
TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
ATE384058T1 (de) | Thiazolderivate | |
MA30821B1 (fr) | Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes | |
SE0401342D0 (sv) | Therapeutic compounds | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
NO20071314L (no) | Peptidiske vasopressinreseptoragonister | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
WO2008008701A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |